interchangeability and postmarketing pharmacovigilance of biosimilars
Published 6 years ago • 141 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
2:03
biosimilars interchangeability
-
1:50
interchangeability of biosimilars - video explainer
-
2:45
immunogenicity and biosimilars
-
52:19
biosimilars – interchangeability / substitution and advertising
-
20:01
biosimilars training program 2022- improving biosimilar pharmacovigilance
-
2:46
interchangeability 101 - biosimilars & interchangeable biologics
-
40:51
biologics and biosimilars interchangeability: a deep dive with industry experts
-
31:52
season 2 episode 6: transforming clinical operations: what comes next?
-
3:00
biosimilars: complex copycat drugs
-
46:47
bispecific antibody overview & production with crossmab technology
-
4:20
the concept of interchangeability
-
8:20
pharmacovigilance requirements for biosimilar products
-
14:19
regulatory pathway for biosimilars
-
2:43
biosimilar interchangeability
-
9:50
the role of pharmacodynamic biomarkers in biosimilar drug development
-
2:47
biosimilars: approval process
-
2:17
what are biosimilars?
-
2:59
biosimilars initiative
-
0:17
biosimilars: more treatment options
-
0:19
biosimilars—advances in research and development
-
1:44
fast facts about the regulatory approval pathway for biosimilars – amgen science